Last week, the Technical Table made up of AIFA e FNOMCeO who, after the signing of the memorandum of understanding, will remain in office for two years.
Various topics were immediately discussed: among them the optimal use of medicines, the best awareness of the clinical and operational implications in their use, ethics and deontology in clinical research and prescribing, independent information from also be implemented through the dissemination of communication campaigns managed by AIFA. Two working groups were formed: the first on drugs subjected to a therapeutic plan, with the simplification of monitoring and follow-up paths; the second on antimicrobial resistance.
“The meeting was a fruitful exchange of views on issues of great relevance and interest: we thank AIFA, in particular the Director General, Nicola Magrini, and the President, Giorgio Palù, for sharing with us the opportunity for an institutional discussion – observed the President of FNOMCeO, Filippo Anelli -. The starting point was the manifestation, on our part, of the need to abandon the path of “administered medicine”, which looks above all to the reasons for the economic balance, in favor of a medicine that has as its objective the health of citizens. An objective that can only be achieved through the application of the principles of autonomy, independence, responsibility of the medical and dental profession, as also noted by the Constitutional Court “.
The AIFA DG Magrini underlined: “we are aware of the role that the agency holds in the high administration of drugs, as well as of the direct responsibilities of doctors and dentists in their prescription and administration. For this reason, following a far-sighted impulse provided by the Ministry of Health, we quickly activated a memorandum of understanding with the FNOMCeO from which we expect results, already in the short term, in terms of appropriateness in pharmaceutical uses and shared information. “
